Mr Ryan Chin Taw Cheong

Professional statement

Mr Ryan Chin Taw Cheong is a consultant ENT and sub-specialist sleep surgeon at the renowned Royal National ENT and Eastman Dental Hospitals, part of University College London Hospitals NHS Foundation Trust. Notably, he is the only consultant ENT surgeon in the UK with a full-time NHS practice exclusively dedicated to snoring and obstructive sleep apnoea.

A highly accomplished surgeon, Mr Cheong has received multiple awards from esteemed organizations such as the Royal Society of Medicine, the Royal College of Surgeons of England, and the British Rhinological Society. His advanced surgical training spans the entire spectrum of ENT, honed at prestigious institutions including the Royal Marsden Hospital, Great Ormond Street Hospital, and the Royal London Hospital.

A leader in his field, Mr Cheong achieved a groundbreaking milestone by performing the UK’s first Inspire hypoglossal nerve stimulator implant for sleep apnoea on a female patient. He also established the UK’s first International Sleep Surgery Course, accredited by ENT-UK, and is its Founder and Course Director. Additionally, he holds the distinction of being the first UK surgeon to complete the Royal Society of Medicine Ellison-Cliffe Travelling Fellowship at Stanford University Hospital Sleep Medicine Division and the Dowager Countess Eleanor Peel Trust Travelling Fellowship at the Asia Sleep Surgery Centre in Singapore.

Mr Cheong is widely recognized for his contributions to academic medicine, delivering over 30 presentations at international and national forums and publishing in high-impact journals such as The Lancet and JAMA. An internationally invited speaker at scientific meetings, he is also deeply committed to training the next generation of ENT surgeons.

His leadership roles in national ENT societies, including the British Society of Facial Plastic Surgery, further reflect his dedication to advancing the specialty. Mr Cheong ensures every patient under his care receives tailored diagnostic and therapeutic treatments that align with the highest international standards.